However, these HbA1c targets only apply if they can be achieved without a clinically important risk of severe hypoglycaemia, defined as events with symptoms of hypoglycaemia requiring help from another person to actively administer oral carbohydrate or inject glucagon or glucose [44]. This evidence concerns the gene GCG and Hypoglycemia.